Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

The majority of patients with refractory, advanced-stage mycosis fungoides (MF) or Sézary syndrome (SS) have a life expectancy of <5 years. Here, we report a phase 2 study of a novel nonmyeloablative allogeneic transplantation strategy tailored for this patient population. This study has complete...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Blood Adv
Prif Awduron: Weng, Wen-Kai, Arai, Sally, Rezvani, Andrew, Johnston, Laura, Lowsky, Robert, Miklos, David, Shizuru, Judith, Muffly, Lori, Meyer, Everett, Negrin, Robert S., Wang, Erica, Almazan, Timothy, Million, Lynn, Khodadoust, Michael, Li, Shufeng, Hoppe, Richard T., Kim, Youn H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Hematology 2020
Pynciau:
Clinical Trials and Observations
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509879/
https://ncbi.nlm.nih.gov/pubmed/32941647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001627
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg